Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
PATHWAYS 8:00 A.M. – 9:30 A. M. 9:30 A.M. – NOON NOON – 12:15 P.M. 12:15 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M 4:45 P.M. – 6:00 P.M.
ACUTE AND STABLE ISCHEMIC HEART DISEASE
609. High Sensitivity Troponin — Ready for Prime Time? Room 217
625. Practical Evaluation of Stable Ischemic Heart Disease: Past, Present and Future Room 217
642. Genetic Testing: New Frontiers in Cardiovascular Care Room 217
626. Advanced Management of Coronary Artery Disease — Thinking Beyond the Routine: Joint Symposium of the Society of Thoracic Surgeons and the American College of Cardiology Room 211
643. Evaluation of Low Risk Chest Pain in the Emergency Department Room 211
ARRHYTHMIAS AND CLINICAL EP
607. Preventing Sudden Cardiac Death in the Young Room 357
623. Device Mini-Debates — Making Complex Choices in Uncertain Areas Room 357
641. Management of Arrhythmias in Cardiac Sarcoidosis: Bench to Bedside Room 357
608. Contemporary Treatment of Atrial Fibrillation in 2019 — Thromboembolic Risk Reduction, Ablation and Prevention: Joint Symposium of the Heart Rhythm Society and the American College of CardiologyRoom 355
624. ACC/AHA/HRS and ESC Guidelines on Syncope: Case-Based Studies Room 355
801. Core Curriculum: Advances in EP Devices and ProceduresRoom 343
CONGENITAL HEART DISEASE600. Catheter and Surgical Therapy for Congenital Heart Disease: It’s Not the Big Easy Room 338
610. Fetal Cardiology: Today’s Challenging Cases and Tomorrow’s Promising Therapies Room 338
627. Imaging Innovation Hub for Congenital Heart Disease Room 338
644. Hot Takes on Acquired Pediatric Heart Disease Room 338
HEART FAILURE AND CARDIOMYOPATHIES
601. Best Practices in Heart Failure: “How To” With the Experts Room La Nouvelle B
611. Hypertrophic Cardiomyopathy: More Than Just Myofibrillar Disarray Room La Nouvelle B
628. Clinical Pearls in Managing HFpEF Room La Nouvelle B
646. The Intersection of Heart Failure and Diabetes Room La Nouvelle B
613. Cardiogenic Shock: State of the Art Management Strategies Room 254
629. Cardio-Oncology Case Challenges: Discussion with the Experts Room La Nouvelle C
645. Exercise Training in Heart Failure: Our Call to Action Room La Nouvelle C
602. The Right Quality and Performance Metrics and Right Outcomes in Heart Failure Room 257
612. The RV: How to Make it “Right”Room 257
630. Acute Heart Failure: What Do We Know? Where Can We Go? Room 257
647. Frailty in Heart Failure Care: It Isn’t Just About Age Room 257
501. Heart Failure Advocacy and International PerspectivesRoom 225
Saturday MARCH 16
accscientificsession.orgDYNAMIC PROGRAM CHART
Information is current as of January 11, 2019
1
PATHWAYS 8:00 A.M. – 9:30 A. M. 9:30 A.M. – NOON NOON – 12:15 P.M. 12:15 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M 4:45 P.M. – 6:00 P.M.
INTERVENTIONAL CARDIOLOGY
200. Interventional Live Case Session I: Coronary Transmission from Beth Israel Deaconess Medical CenterACC.19 Main Tent, Great Hall
201. Interventional Live Case Session II: Peripheral Transmission from Piedmont Heart Institute ACC.19 Main Tent, Great Hall
202. Interventional Live Case Session III: Coronary Transmission from Beth Israel Deaconess Medical CenterACC.19 Main Tent, Great Hall
604. Great Debates in Vascular Intervention Room 208
616. Future of Aortic Valve Surgery in Low-risk Patients: Dilemmas in the Era of Catheter-Based Valve Therapy Room 208
633. Mitral Valve Interventions: Transcatheter Mitral Valve Repair Room 208
650. Transcatheter Valve Repair/Replacement: Expanding Indications Room 208
605. Frontiers in Coronary Physiology: Building Knowledge to Predict the Future Room 206
617. STEMI Hot Debates: Trials and Tribulations! Room 206
634. 30 Years of TCT — Progress and Controversies in Interventional Cardiology: A Joint Symposium by the Cardiovascular Research Foundation and the American College of Cardiology Room 206
651. Stop it Early or Stop it Late: The Debate Over Antithrombotic Therapy After PCI Room 206
606. MCS for Cardiogenic Shock Cases: The Good, the Bad, and the Ugly Room 203
618. Endovascular Interventions From Head to Toe, Basic to Complex Room 203
635. Stay Away from the Light: Emotional Experiences in the Cath Lab Room 203
652. Best Practices for Large Bore Arterial Access Room 203
615. The Expanding Frontiers of Endovascular Therapy: Updates From the Experts Room 211
803. Core Curriculum: Interventional Cardiology: To Stent or Not to StentRoom 343
NON-INVASIVE IMAGING
603. Man vs. Machine: Current and Future Applications of Machine Learning In Cardiovascular Imaging Room 254
631. Cardiac CT for Diagnosing and Guiding Treatment in Structural Heart Diseases Room 254
648. Advances in Nuclear Cardiology Room 254
614. Clinical Use of CMR Across the Spectrum of Structural Heart Disease Room 244
632. Cutting Edge Echo — You Can Use it Too: Joint Symposium of the American Society of Echocardiography and the American College of CardiologyRoom 244
649. Applying the Echo Guidelines to Clinical Practice: How the Experts Do It — A Case-based Journey Room 244
PREVENTION619. Hypertension Management Hypercharged: The Devil is in the Details Room 228
636. Just Tell Me the Fa(c)ts About the New Cholesterol Guideline! Room 228
6503. E-cigs: Role and Risks Heart 2 Heart Stage, Lounge & Learn
653. So You Know Your Lipids! Let’s Do Some Questions and Discuss Some CasesRoom 228
PULMONARY HYPERTENSION637. State of the Art in Venous Thromboembolism Care Room 352
654. Hot Topics in Pulmonary Vascular Disease Room 352
Saturday MARCH 16
accscientificsession.orgDYNAMIC PROGRAM CHART
2
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A. M. 9:30 A.M. – NOON NOON – 12:15 P.M. 12:15 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M 4:45 P.M. – 6:00 P.M.
SPECIAL TOPICS
400. Opening Showcase Featuring the 2019 Simon Dack KeynoteACC.19 Main Tent, Great Hall
401. Joint American College of Cardiology and Journal of American College of Cardiology Late-Breaking Clinical Trials ACC.19 Main Tent, Great Hall
747. Evaluating Disruptive Technology in a Value Based World Room 352
403. FIT Forum Mix ‘n Mingle ACC Bistro
914. Young Investigators Awards: Basic and Translational Science Lounge & LearnSession ends at 6:30 p.m.
620. Innovation Bootcamp: Training Fellows, Cardiology Educators, and Shaping Innovators Room 243
638. Controversies in Anticoagulation After Cardiac Surgery Room 243
915. Young Investigators Awards: Clinical InvestigationsLounge & LearnSession ends at 6:30 p.m.
50. Clinician Wellness Intensive I: Featuring the 50th Annual Louis F. Bishop KeynoteRoom 225
51. Clinician Wellness Intensive IIRoom 225
655. The Nuts & Bolts of Starting a Niche CV Program at Your Institution: Lipid Clinic, Valve Clinic/Structural Heart Disease Program, Adult Congenital Heart Disease Program and Atrial Fibrillation Clinic Room 243
6500. A Conversation With Dr. Roberto Canessa Heart 2 Heart Stage, Lounge & Learn
6501. How to Navigate ACC.19: An Inside Look at This Year’s ProgramHeart 2 Heart Stage, Lounge & Learn
6510. New ABIM/ACC Collaborative Maintenance Pathway (CMP)Heart 2 Heart Stage, Lounge & Learn
6502. Diversity and Inclusion in Cardiology: Where Are We Headed? Heart 2 Heart Stage, Lounge & Learn
402. Featured Clinical Research I Room La Nouvelle C
656. A Career in Academic Cardiology: Key Points to SuccessRoom 238
6000. FIT Jeopardy: Battle of the State Chapters [email protected] Studio, Expo Hall
6001. The 0’s and 1’s of Digital Health and the Heart: A Primer for the Clinical Cardiologist [email protected] Studio, Expo Hall
6002. FIT Jeopardy: Battle of the State Chapters [email protected] Studio, Expo Hall
6003. Cardiology Contest [email protected] Studio, Expo Hall
800. Test Your Knowledge: Heart Failure and ArrhythmiasRoom R03
802. Test Your Knowledge: Ischemic Heart Disease, Vascular and PreventionRoom R03
804. Cases From the Guidelines for Clinicians Room R03
VALVULAR HEART DISEASE 621. Aortic Insufficiency and Aortopathies Room 220
639. Imaging and Physiologic Testing and its Implication in Valvular Heart Disease Room 220
657. A Dysfunctional Heart: The Role of Myocardial Dysfunction in the Evaluation and Management of Aortic and Mitral Valve Disease — A Case-Based Approach Room 220
VASCULAR MEDICINE622. Vasculo-Oncology 2019: An Emerging Field — Be a Part of It Room 238
640. Bringing up Baby: Vascular Diseases During Pregnancy Room 238
PERSONALIZED SKILLS & SIMULATION CENTER
1501. Hone your auscultation skills with Heart Songs, test your expertise during simulations at the Clinical Judgment Station using Body Interact; improve your patient communication techniques at the Shared Decision-Making Station; challenge your acute heart failure care at the Immersive Station and practice your procedural skills.Lounge & Learn Pavilion, Hall B
POSTERS Poster Presentations Posters and Moderated PostersHall F
Poster Presentations
Saturday MARCH 16
accscientificsession.orgDYNAMIC PROGRAM CHART
3
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A. M. 9:30 A.M. – NOON NOON – 12:15 P.M. 12:15 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M 4:45 P.M. – 6:00 P.M.
EXPO ExpoHall C - E
Expo Break Expo Break Expo Break
NON-
CERT
IFIE
D
FUTURE HUB
The Future of Health Technology and InnovationExpo Hall, #146
Are Clinical Virtual Reality and Augmented Reality Ready for Prime Time?Expo Hall, #146
Build the Bridge Over Troubled Waters: Digital Devices in Heart FailureExpo Hall, #146
The Patient Will See You Now: Building Your Virtual ProgramExpo Hall, #146
Passion, Failure, Pivot, Success: The Life-cycle of a Start-UpExpo Hall, #146
INDUSTRY-EXPERT THEATER 1
4001. Empowering the Transformation of Heart Failure by Abbott VascularExpo Hall, #1967
4002. Improving Outcomes for Hospitalized Patients with HFrEF: Looking Beyond Stabilization by Novartis Pharmaceuticals CorporationExpo Hall, #1967
4003. Reversal of Novel Oral Anticoagulants in Patients Experiencing Life Threatening Bleeds: Review of Clinical Evidence and Practice Recommendations for Patient Management by Portola PharmaceuticalsExpo Hall, #1967
INDUSTRY-EXPERT THEATER 2
4009. Lower Together: LDL-C, Risk, Hassle, Cost by Amgen Expo Hall #2467
4010. Get the Diagnosis Right: Identifying Amyloidosis in Your Patients by Alynlam Pharmaceuticals Expo Hall, #2467
4011. Jardiance® (empagliflozin) Tablets: Data From the Comprehensive Clinical Development Program by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USAExpo Hall, #2467
INNOVATION STAGE
4201. PRALUENT (alirocumab) Injection: The Time to Treat is Now by Sanofi-Regeneron Expo Hall, #2519
4202. Advances in the Management of CAD/PAD: A New Treatment for Thrombotic Risk Reduction by Janssen Pharmaceuticals, Inc.Expo Hall, #2519
4203. Advances in the Management of CAD/PAD: A New Treatment for Thrombotic Risk Reduction by Janssen Pharmaceuticals, Inc.Expo Hall, #2519
4204. Advances in the Management of CAD/PAD: A New Treatment for Thrombotic Risk Reduction by Janssen Pharmaceuticals, Inc. Expo Hall, #2519
4205. Modern Afib Treatments for a Better Tomorrow by Biosense Webster, Inc.Expo Hall, #2519
INTERACTIVE LEARNING LAB Presented By Lundbeck Expo Hall, #1757
Saturday MARCH 16
accscientificsession.orgDYNAMIC PROGRAM CHART
4
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M. 4:45 P.M. – 6:00 P.M.
ACUTE AND STABLE ISCHEMIC HEART DISEASE
509. Acute Coronary Syndrome With ST Elevation: Experience from Real World Room 243
708. Masters Athletes and Coronary Artery Disease: From Risks to the Finish LineRoom 357
659. Acute Cardiogenic Shock: Progress, Paradigms, and Problems Room 217
671. Updates on Antiplatelet Management Room 217
685. Discussions on Revascularization for Stable Ischemic Heart DiseaseRoom 217
698. Myocardial Infarction with Non-Obstructive Coronary Arteries: It’s Time to Look Beyond the Surface! Room 217
709. Analyzing the Data: Blockbuster Trials in Acute and Stable Ischemic Heart Disease Room 217
672. Dissecting the Data: 2019 Update on Spontaneous Coronary Artery Dissection Room 211
686. Ongoing Debates in the Management of Patients with STEMI Room 211
699. Challenges in NSTEMI Management: It’s Not Always “Easy Street”! Room 211
ARRHYTHMIAS AND CLINICAL EP
900. Highlighted Original Research: Arrhythmias and Clinical EP and the Year in Review Room 357
503. Management of Atrial FibrillationRoom 357
684. Conundrums of Pro-arrhythmia: A Case-based Approach to Medication Induced Harms Room 357
696. Disputing AF Management: What Does the Evidence Support? Room 357
658. Parsing the Guidelines: New Insights on Bradycardia, Ventricular Arrhythmias, Lead Management, and Arrhythmogenic Cardiomyopathies Room 355
670. Pushing the Boundaries: When Arrhythmias Complicate End Stage Heart Failure Room 355
6005. Ask the EP [email protected] Studio, Expo Hall
697. Symptoms in the Athlete: How to Evaluate and What Not to Miss Room 355
CONGENITAL HEART DISEASE
660. On the Cutting Edge of Congenital Aortic Valve Disease — Surgical Options in 2019: Joint Symposium of the American Association for Thoracic Surgery and the American College of CardiologyRoom 338
673. Heart Failure in Pediatric and Congenital Heart Disease: Case-based Conversations With the Experts Room 338
687. Innovations in Pediatric Cardiac Care: A Peak Around the Corner Room 338
700. Rhythm and Blues: Electrophysiology Progress and Controversies in Congenital Heart Disease Room 338
6008. Family Feud: Heart Teams [email protected] Studio, Expo Hall
HEART FAILURE AND CARDIOMYOPATHIES
661. Kanu and Docey Chatterjee Keynote and Seminal Talks in Heart Failure — Guidelines, Challenges, and the Pathway for Success: Learn from the Experts Room La Nouvelle B
674. Update in Diagnosis and Management of Acute Myocarditis: Joint Symposium of the Heart Failure Society of America and the American College of CardiologyRoom La Nouvelle B
701. HFpEF: Why Is My Patient Huffing and Puffing? How Can We Help? Room 225
711. The Durability of Mechanical Support Room La Nouvelle B
662. Timely Topics in Transplantation Room 257
675. Uncommon Cardiomyopathies: Lesser Seen But Still Important Room 257
688. The Current Landscape in Cardio-Oncology Room 257
702. Amyloid Cardiomyopathy: The Starry Future Room 257
712. Joint Symposium of the American Heart Association and the American College of Cardiology Room 257
807. Core Curriculum: The Failing Heart — Strategies to Improve Outcomes Room 343
710. Hemodynamics in Heart Failure: Understanding the Fundamentals Room 338
Sunday MARCH 17
accscientificsession.orgDYNAMIC PROGRAM CHART
5
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M. 4:45 P.M. – 6:00 P.M.
INTERVENTIONAL CARDIOLOGY
6504. Storytellers: Art, Passion, Faith, and FamilyHeart 2 Heart Stage, Lounge & Learn
203. Interventional Live Case Session IV: Coronary Transmission from University of Washington Medical CenterACC.19 Main Tent, Great Hall
204. Interventional Live Case Session V: Structural Transmission from Piedmont Heart InstituteACC.19 Main Tent, Great Hall
205. Interventional Live Case Session VI: Coronary Transmission from University of Washington Medical CenterACC.19 Main Tent, Great Hall
665. Must Have Endovascular Skills: Fundamentals, Advanced Techniques and Complication Management Room 211
714. When Twitter Cases Come to the Lab: #SoMe @ ACC Room 211
901. Highlighted Original Research: Interventional Cardiology and the Year in Review Room 208
904. Structural Heart Disease Interventional Challenging Cases Room 208
691. Needle, Knives and Screws: Challenges and Conundrums in HCM Room 208
300. Fellows Bootcamp: Coronary Disease Management Room 208
301. Fellows Bootcamp: Structural Room 208
666. Transcatheter Mitral and Tricuspid Valve Interventions: Imaging Determines Success Room 206
678. Sunday Night Debates: Current Controversies in Transradial Angiography and Intervention Room 206
692. Aortic Valve Interventions: New Indications Room 206
408. Featured Clinical Research II: Interventional Room 206
715. Right Sided Valve Disease Interventions Room 206
667. Complex and High-Risk PCI: A Case Based Joint Symposium by the Society of Cardiovascular Angiography and Interventions and the American College of Cardiology Room 203
504. TAVR: From Valve to Ventricle EvaluationRoom 203
693. Multidisciplinary Team-Based Care for Cardiogenic Shock: Case-Based Approach Room 203
705. Next-level Knowledge in TAVR Through Multidisciplinary Collaboration Room 203
716. Open Mic With Cardiologists: My Top Five Pain Points Room 203
NON-INVASIVE IMAGING
663. Assessment of Diastolic Function Using Echocardiography: What Do I Need to Know in 2019? Room 254
676. CMR in Clinical Cardiology: The Clinician and Imager Perspectives Room 254
689. Point-of-Care Cardiac Ultrasound: Use It or Lose It Room 254
703. CMR Guided Care: Is it Time for a Paradigm Shift? Joint Symposium from the Society for Cardiovascular Magnetic Resonance and American College of CardiologyRoom 254
720. Cutting Edge Cardiac CT: Joint Symposium from the Society of Cardiovascular Computed Tomography and American College of CardiologyRoom 352
664. Great Debates in Cardiac CT Room 244
677. Conundrums in Cardio-Oncology: Imaging and Beyond Room 244
690. Cardiac Amyloidosis: A Multimodality Approach Room 244
704. Current Controversies in Echocardiography Room 244
713. Concepts and Controversies in Interventional Echo Room 244
PREVENTION
668. Can We Optimize CVD Care Using Genetics, Digital Health and Microbiome? Room 228
679. Changing Paradigm in Cardiovascular Risk Reduction in Diabetes Room 228
694. Hypertension Treatment in the Era of Precision Medicine Room 228
706. Great Debates in Clinical Lipidology in 2019 Room 228
717. How Does Ethnicity Impact Cardiometabolic Risk? Room 228
502. From Primary to Secondary Cardiovascular Prevention Room 225
680. New Paradigms in Contemporary Cardiovascular Care: Application of Guideline-Directed Therapies — Implications for Minority Populations and Resolution of Disparities: Joint Symposium of the Association of Black Cardiologists and the American College of CardiologyRoom 225
775. Prevention GuidelinesRoom La Nouvelle B
718. LDL-C and Beyond: Harnessing the Power of Novel Therapeutic Targets and Big Data to Improve Dyslipidemia Care Room 225
805. Core Curriculum: Prevention — Primer in CVD Room 343
PULMONARY HYPERTENSION902. Highlighted Original Research: Pulmonary Hypertension and Venous Thrombo-Embolic Disease and the Year in Review Room 352
681. A Panoply of Perspectives on Pulmonary Hypertension: Patients, Practitioners, and Political Advocates Room 352
809. Core Curriculum: Update on Pulmonary Hypertension and Venous Thromboembolism Management Room 343
510. Pulmonary Hypertension: From Etiology to TherapyRoom 352
Sunday MARCH 17
accscientificsession.orgDYNAMIC PROGRAM CHART
6
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M. 4:45 P.M. – 6:00 P.M.
SPECIAL TOPICS
404. Late-Breaking Clinical Trials II ACC.19 Main Tent, Great Hall
405. Late-Breaking Clinical Trials III ACC.19 Main Tent, Great Hall
406. 18th Annual Maseri-Florio International Keynote Room 355
Clinical Focus SessionRoom 355 Session ends at 6:30 p.m.
505. Joint Symposium of the Chinese Society of Cardiology and American College of CardiologyRoom 352
508. 7th Annual Conquering Healthcare Challenges in the Emerging Worlds SymposiumRoom 352
407. LBCT Deep Dive I Room 343
Clinical Focus Session Room 343 Session ends at 6:30 p.m.
100. Cardiovascular Update for the Clinician I: Coronary Artery Disease — Challenges in 2019: A Symposium by Valentin FusterRoom La Nouvelle C
102. Cardiovascular Update for the Clinician II: Chronic Coronary and Systemic Disease 2019: A Symposium by Valentin FusterRoom La Nouvelle C
104. Cardiovascular Update for the Clinician III: Cardio-Pulmonary and Electrical Failure in 2019: A Symposium by Valentin Fuster Room La Nouvelle C
106. Cardiovascular Update for the Clinician IV: Rhythm Disorders: A Symposium by Valentin Fuster Room La Nouvelle C
108. Cardiovascular Update for the Clinician V: Valvular Heart Disease and IHSS in 2019: A Symposium by Valentin Fuster Room La Nouvelle C
101. Pharmacology Session I: Clearing the Air on Pulmonary Arterial HypertensionRoom 238
103. Pharmacology Session II: It’s All About Me: Individualizing Your Approach to StatinRoom 238
105. Pharmacology Session III: Hot Topics in CV Pharmacology: Pearls and PitfallsRoom 238
905. FIT Forum: Stump the Professor Room 238
913. ACC Research Awards Lounge & Learn
506. International Perspectives From the European Society of Cardiology I and American College of Cardiology: The European Heart Journal’s Year in Cardiology Room La Nouvelle B
916. Young Investigators Awards: Outcomes Research Lounge & Learn
6004. FIT Jeopardy: Battle of the State Chapters [email protected] Studio, Expo Hall
6505. Social Media for Today’s Cardiologist: A Necessary Professional Pathway or a Potentially Dangerous Fad for CV Science Heart to Heart Stage: Lounge & Learn
774. WIC Brown Bag Lunch Session: Advocating for Yourself, Your Institution and Your Patients Room 225
6006. FIT Jeopardy: Battle of the State Chapters [email protected] Studio, Expo Hall
6007. FIT Jeopardy: Battle of the State Chapters [email protected] Studio, Expo Hall
6506. Making the Most Out of ACC.org: Optimizing Your Expe-rience With Your Digital Home Heart 2 Heart Stage, Lounge & Learn
6507. Transition: Shifting Focus in the Latter Years of Your CV Career Heart 2 Heart Stage, Lounge & Learn
806. Test Your Knowledge: Ischemic/Vascular/Prevention Room R03
808. Test Your Knowledge: Failure and ArrhythmiasRoom R03
810. Test Your Knowledge: Valvular and Congenital Room R03
507. International CV Centers of Excellence and CV Quality Room 243
719. Addressing Barriers to Women Entering and Advancing in Cardiology Room 243
VALVULAR HEART DISEASE669. Aortic Disease: Surveillance, Replacement and Return to Life Room 220
682. Every Storm Runs out of Rain: Valvular Heart Disease and Pregnancy — From Preconception Counseling to Delivery and Thereafter Room 220
695. Tricuspid Valve: The Middle Child of Valvular Heart Disease? Room 220
707. Improving TAVR Outcomes: It’s Not Just the Valve! Room 220
721. The Road to Transcatheter Mitral Valve Therapies Room 220
VASCULAR MEDICINE903. Highlighted Original Research: Vascular Medicine and the Year in Review Room 243
722. Aortic Dilemmas in the Cardiology Clinic Room 254
Sunday MARCH 17
accscientificsession.orgDYNAMIC PROGRAM CHART
7
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 4:45 P.M. 4:45 P.M. – 6:00 P.M.
PERSONALIZED SKILLS & SIMULATION CENTER
1502. Hone your auscultation skills with Heart Songs, test your expertise during simulations at the Clinical Judgment Station using Body Interact; improve your patient communication techniques at the Shared Decision-Making Station; challenge your acute heart failure care at the Immersive Station and practice your procedural skills.Lounge & Learn Pavilion, Hall B
POSTERS Poster Presentations Posters and Moderated PostersHall F
Poster Presentations
EXPO Expo Break ExpoHall C-E Expo Break Expo
Hall C-E Expo Break
NON-
CERT
IFIE
D
FUTURE HUBACC.19 Innovation Challenge: Artificial Intelligence SolutionsExpo Hall, #146
Opening Pandora’s Box: The Pros and Cons of Direct-to-Consumer Medical DevicesExpo Hall, #146
Augmented Cardiovascular Practitioner: Giving Doctors and Patients a New VoiceExpo Hall, #146
Genomic Risk Prediction: From Bench to ClinicExpo Hall, #146
TelePCI: At the Edge of the Playing FieldExpo Hall, #146
INDUSTRY-EXPERT THEATER 1
4004. A Hospitalization for Heart Failure: A Bad Omen or an Opportunity?by Novartis Pharmaceuticals CorporationExpo Hall, #1967
4005. Presentation by Akcea Therapeutics Expo Hall, #1967
4006. Topic: Heart Failure by Novartis Pharmaceuticals CorporationExpo Hall, #1967
INDUSTRY-EXPERT THEATER 2
4012. Who Are The Highest Risk CV Patients & How Do We Manage Them? A Focus on Post-MI and PAD by AmgenExpo Hall, #2467
4013. Lower Together: LDL-C, Risk, Hassle, Cost by Amgen Expo Hall, #2467
4014. Understanding the Spectrum of LDL-C in CV Disease: A Focus on Low LDL by AmgenExpo Hall, #2467
INNOVATION STAGE
4206. Patient Outcomes Matter: Contemporary Management of Heart Disease to Complete Revascularization by Boston Scientific Expo Hall, #2519
4207. Heart Rate in Heart Failure: Hospitalization Risk and Health Related Quality of Life Description by Amgen Expo Hall, #2519
4208. I’m Afraid to Faint Again: Overview of Neurogenic Orthostatic Hypotension Diagnosis and Management by LundbeckExpo Hall, #2519
4209. Patient Stands Up, Blood Pressure Goes Down: Diagnostic and Management Consider-ations for Symptomatic Neurogenic Orthostatic Hypotension by LundbeckExpo Hall, #2519
INTERACTIVE LEARNING LAB Presented by Lundbeck Expo Hall, #1757
Sunday MARCH 17
accscientificsession.orgDYNAMIC PROGRAM CHART
8
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 3:45 P.M. 3:45 P.M. – 5:15 P.M.
ACUTE AND STABLE ISCHEMIC HEART DISEASE
724. CCU Conundrums: What Would You Do? Room 357
764. Diagnostic Testing in Older Adult Patients with Coronary Artery Disease: Choosing WiselyRoom 357
725. Refractory Angina: Options for Patients With “No Options” Room 217
735. Controversies in ACS Guidelines and Actual Care: What the Experts Don’t Always Tell You Room 217
750. Triple-Doubles in Clinical Practice: Should “Double Therapy” Replace “Triple Therapy” When Anticoagulation and Antiplatelet Therapy Are Needed? Room 217
765. Ischemia and No Obstructive Coronary Arteries: It Doesn’t Always End With the Angiogram! Room 217
811. Core Curriculum: Acute and Stable Ischemic HD: Myocardial Infarction in Women Room 343
6010. Get Inspired by the Legends in Cardiovascular Medicine [email protected] Studio, Expo Hall
906. Highlighted Original Research: Acute and Stable Ischemic Heart Disease and the Year in Review Room 211
515. Diabetes: Risk Factor or Cardiovascular Disease? Room 211
751. Cardiac Rehab 2019 and Beyond Room 211
ARRHYTHMIAS AND CLINICAL EP
733. Connected and Wearable Technologies for Arrhythmia Management and Detection Room 357
748. Practical ECGs With the Experts: Hallmarks of High Risk Room 357
723. Anti-coagulation in AF With Heart Disease: How to Manage Common and Uncommon Challenges Room 355
734. Learning from Recent Clinical Trials: Perspectives on CABANA, CASTLE AF, VEST and ORBITA Room 355
749. On the Horizon in Electrophysiology Room 355
1400. Arrhythmias and Clinical EP Highlights Session Room 355
CONGENITAL HEART DISEASE907. Highlighted Original Research: Congenital Heart Disease and the Year in Review Room 338
736. Promoting Progress in Congenital Heart Disease: Featuring the Dan G. McNamara Keynote Room 338
752. Practicing Prevention in Pediatric and Adult Congenital Cardiology Clinics Room 338
766. Pregnancy and Women’s Health in Congenital Heart Disease Room 338
HEART FAILURE AND CARDIOMYOPATHIES
726. Pregnancy and Cardiovascular Disease: At the Heart of Mother and the Baby Room La Nouvelle B
737. Cardiorenal Syndrome in Heart Failure: Balancing the Needs of the Heart and Kidney Room La Nouvelle B
516. Heart Failure: From Guidelines to Real World Room La Nouvelle B
767. Biomarkers in Heart Failure: In Search of Precision Medicine Room La Nouvelle B
908. Highlighted Original Research: Heart Failure and Cardiomyopathies and the Year in Review Room 257
738. eHeart Failure: Designing, Documenting, Delivering Room 257
753. Being Mortal: End of Life Care For Patients With Heart Failure Room 257
768. Implantable Devices in Ambulatory Heart Failure: Working Under Pressure Room 257
754. Careers in Heart Failure and Transplant Symposium Room 254
1401. Heart Failure Highlights Session Room 228
Monday MARCH 18
accscientificsession.org
Information is current as of January 11, 2019
DYNAMIC PROGRAM CHART
9
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 3:45 P.M. 3:45 P.M. – 5:15 P.M.
INTERVENTIONAL CARDIOLOGY
728. LAA Closure: Challenging Cases and New Evidence Room 208
741. LAA Closure: Pre and Post-Procedure Assessment, and PFO: TEE and ICE Room 208
756. Highlights in Non-valvular Structural Intervention Room 208
770. Deep Dive in Influential Interventional Clinical Trials Room 208
729. Physiology and Intravascular Imaging During ACS Room 206
742. Aortic Valve Interventions: Clinical Dilemmas Room 206
757. Complex Angioplasty: Controversies in Procedural Decision Making Room 206
771. Precision PCI: Use of Intravascular Imaging and Physiology to Optimize Results Room 206
910. Coronary and Peripheral Interventional Challenging Cases Room 203
743. Interventional Heart Failure Room 203
758. Updates in Structural Interventional Cardiology for the CV Team Room 203
772. Quick Hitters: Current Controversies in Coronary Interventions Room 203
769. Concomitant Valve Disease Management: Patient-tailored Therapy for the Intermediate Risk Patient Room 211
NON-INVASIVE IMAGING
909. Highlighted Original Research: Non-Invasive Imaging and the Year in Review Room 254
512. How To Integrate Non-Invasive ImagingRoom 254
1402. Imaging Highlights Session Room 254
727. New and Emerging Applications of Nuclear Imaging for the Practicing Cardiologist: What Is the Right Test and the Right Patient? Joint Symposium of the American Society of Nuclear Cardiology and the American College of CardiologyRoom 244
740. Congenital Imaging for the General Cardiologist: A Case-based Discussion Room 244
755. Comprehensive Echocardiographic Assessment of Valvular Heart Disease Room 244
812. Core Curriculum: Imaging in Heart Failure Assessment Room 343
739. Stress Echocardiography Workshop: Beyond Wall Motion — Cases to Remember! Room La Nouvelle C
PREVENTION
730. Pearls In Lifestyle Related Prevention Every Cardiology Practitioner Needs to Know Room 228
744. All You Needed to Know About Cardiovascular Disease Prevention Guidelines, Well — Almost All Room 228
759. The Devil Is in the Details: A Case-Based Discussion on Cholesterol Guidelines Room 228
911. Highlighted Original Research: Prevention and the Year in Review Room 225
745. The Great Dietary Pattern Debate Room 225
760. Beyond the New Hypertension Guidelines: Understanding & Implementing in Current Practice Room 225
1403. Prevention Highlights Session Room 225
PULMONARY HYPERTENSION731. A Glimpse Into the Future of Pulmonary Vascular Disease Management Room 352
746. Relieving the Pressure of Pulmonary Arterial Hypertension: Key Takeaways for the General Cardiologist Moving from Vague Symptoms to Ensuring Adequate Treatment Response Room 352
Monday MARCH 18
accscientificsession.orgDYNAMIC PROGRAM CHART
10
Information is current as of January 11, 2019
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M. – 3:45 P.M. 3:45 P.M. – 5:15 P.M.
SPECIAL TOPICS
409. Late-Breaking Clinical TrialsACC.19 Main Tent, Great Hall
410. Late-Breaking Clinical TrialsACC.19 Main Tent, Great Hall
411. Best of JACC Journals and the Eugene Braunwald KeynoteACC.19 Main Tent, Great Hall
517. Tackling Rheumatic Heart Disease in Adults — A Global Perspective: Joint Symposium of the World Heart Federation and the American College of Cardiology Room 244
68th Annual Convocation Ceremony Followed by a Reception ACC.19 Main Tent, Great Hall
732. Acing the Transition: What FITs Need to Know to Launch a Healthy, Successful Career Room 238
513. 11th ACC Cardiovascular Conference on the Middle East Room 244
761. Succeeding in Alternate Payment Models Room 352
1404. Sports Highlights Session Room 352
511. International Perspectives From the European Society of Cardiology II and American College of Cardiology: Cardiac Care for the Diabetic Patient — Fast-Paced Practical Advice Based on Current Guidelines Room La Nouvelle C
6508. Demystifying the FDAHeart 2 Heart Stage, Lounge & Learn
6509. Rise of Intelligent Machines: The Potential of Artificial Intelligence in Cardiovascular Care Heart 2 Heart Stage, Lounge & Learn
412. LBCT Deep Dive II Room La Nouvelle C
413. Featured Clinical Research III Room La Nouvelle C
VALVULAR HEART DISEASE
912. Highlighted Original Research: Valvular Heart Disease and the Year in Review Room 220
514. Infective Heart Disease Room 220
762. Pitfalls in Valve Intervention Room 220
773. The Role of Vasculature in Valvular Heart Disease Room 220
814. Core Curriculum: Valvular Heart Disease in the Percutaneous Era Room 343
VASCULAR MEDICINE
6009. Vascular Innovation Shark Tank [email protected] Studio, Expo Hall
763. Ambulation to Rivaroxaban: Branching Outside the Coronaries Room 238
1405. Vascular Highlights Session Room 238
813. Core Curriculum: Update on Management of Peripheral Vascular Disease Room 343
PERSONALIZED SKILLS & SIMULATION CENTER
1503. Hone your auscultation skills with Heart Songs, test your expertise during simulations at the Clinical Judgment Station using Body Interact; improve your patient communication techniques at the Shared Decision-Making Station; challenge your acute heart failure care at the Immersive Station and practice your procedural skills.Lounge & Learn, Hall B
POSTERS Poster Presentations Posters and Moderated PostersHall F
Monday MARCH 18
accscientificsession.org
Information is current as of January 11, 2019
DYNAMIC PROGRAM CHART
11
EXPO
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:0
0
10:1
5
10:3
0
10:4
5
11:0
0
11:1
5
11:3
0
11:4
5
12:0
0
12:1
5
12:3
0
12:4
5
1:30
1:45
2:00
2:15
2:30
2:45
3:00
3:!5
3:30
3:$5
4:00
4:15
4:30
4:45
5:00
PATHWAYS 8:00 A.M. – 9:30 A.M. 9:30 A.M. – 10:45 A.M. 10:45 A.M. – 12:15 P.M. 12:15 P.M. – 12:30 P.M. 12:30 P.M. – 1:45 P.M. 1:45 P.M. –
2:00 P.M. 2:00 P.M. – 3:30 P.M. 3:30 P.M.– 3:45 P.M. 3:45 P.M. – 5:15 P.M.
EXPO Expo Break ExpoHall C–E Expo Break
NON-
CERT
IFIE
D
FUTURE HUBACC.19 Innovation Challenge: Digitally Enabled Medical Devices Expo Hall, #146
Finding the Clinician Entrepreneur and Establishing an Innovation ProgramExpo Hall, #146
Highlights from the Future Hub: What You Need to Know about the Future of Health Technology and InnovationExpo Hall, #146
INDUSTRY-EXPERT THEATER 1
4007. Presentation by Siemens HealthineersExpo Hall, #1967
4008. Presentation by ZOLLExpo Hall, #1967
INDUSTRY-EXPERT THEATER 2
4015. Exploring A1C and Cardiovascular Safety Data in T2D Therapies by Novo Nordisk Expo Hall, #2467
4016. Presentation To Be AnnouncedExpo Hall, #2467
INNOVATION STAGE
4210. Kidney Care Protocols in the Cath Lab: Reduce the Risk of AKI in High Risk Patients by Osprey Medical Expo Hall, #2519
4211. Presentation to be Announced Expo Hall, #2519
INTERACTIVE LEARNING LAB Presented by LundbeckExpo Hall, #1757
Monday MARCH 18
accscientificsession.org
Information is current as of January 11, 2019
DYNAMIC PROGRAM CHART
12